ID

39972

Description

Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration

Keywords

Versions (1)
  1. 3/6/20 3/6/20 -
Copyright Holder

GlaxoSmithKline

Uploaded on

March 6, 2020

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055

English

Week 28 - Eye Drop Administration; Treatment Preference Questionnaire

1 forms  
Treatment Preference Questionnaire
Description

Treatment Preference Questionnaire

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0558295
UMLS CUI-3
C0034394
Date of Assessment
Description

Date of Assessment

Data type

date

Alias
UMLS CUI [1]
C2985720
Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?
Description

Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?

Data type

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C1272700
UMLS CUI [2,2]
C0087111
UMLS CUI [3]
C0558295
Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?
Description

Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?

Data type

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C1331418
UMLS CUI [2,2]
C0087111
UMLS CUI [3]
C0030193
UMLS CUI [4]
C2364135
UMLS CUI [5]
C1706307
UMLS CUI [6]
C4061283
UMLS CUI [7,1]
C0087111
UMLS CUI [7,2]
C0558295
Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?
Description

Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?

Data type

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C1527305
UMLS CUI [2,2]
C0087111
UMLS CUI [2,3]
C0004083
UMLS CUI [3]
C0027769
UMLS CUI [4]
C4054984
UMLS CUI [5]
C0003467
UMLS CUI [6]
C0700361
UMLS CUI [7,1]
C0087111
UMLS CUI [7,2]
C0558295
Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?
Description

Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?

Data type

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2]
C4049986
UMLS CUI [3]
C0871707
UMLS CUI [4,1]
C0087111
UMLS CUI [4,2]
C0558295
Question 5a. If you could only have one treatment, which would you choose?
Description

Question 5a. If you could only have one treatment, which would you choose?

Data type

integer

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C1707391
Question 5b. What is the single most important reason for your choice?
Description

Question 5b. What is the single most important reason for your choice?

Data type

text

Alias
UMLS CUI [1]
C1522634
UMLS CUI [2,1]
C0392360
UMLS CUI [2,2]
C1707391
Eye Drop Administration
Description

Eye Drop Administration

Alias
UMLS CUI-1
C0015399
UMLS CUI-2
C1533734
Who has been primarily responsible for administering the medication (eye drops) over the study?
Description

Who has been primarily responsible for administering the medication (eye drops) over the study?

Data type

text

Alias
UMLS CUI [1,1]
C0015399
UMLS CUI [1,2]
C1533734
UMLS CUI [1,3]
C0678341
UMLS CUI [1,4]
C0008976
UMLS CUI [1,5]
C0347984
If other person is responsible for administering the medication, specify
Description

If other person is responsible for administering the medication, specify

Data type

text

Alias
UMLS CUI [1,1]
C0015399
UMLS CUI [1,2]
C1533734
UMLS CUI [1,3]
C0678341
UMLS CUI [1,4]
C0205394
UMLS CUI [1,5]
C2348235
Back to the top of the page

Similar models

Week 28 - Eye Drop Administration; Treatment Preference Questionnaire

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Treatment Preference Questionnaire
C0087111 (UMLS CUI-1)
C0558295 (UMLS CUI-2)
C0034394 (UMLS CUI-3)
Date of Assessment
Item
Date of Assessment
date
C2985720 (UMLS CUI [1])
Item
Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C1272700 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0558295 (UMLS CUI [3])
Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?
Code List
Question 1. Overall, with respect to ease of treatment, which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C1331418 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0030193 (UMLS CUI [3])
C2364135 (UMLS CUI [4])
C1706307 (UMLS CUI [5])
C4061283 (UMLS CUI [6])
C0087111 (UMLS CUI [7,1])
C0558295 (UMLS CUI [7,2])
Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?
Code List
Question 2. Overall, with respect to comfort of treatment (e.g., pain, discomfort, irritation or other physical distress) which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C1527305 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0004083 (UMLS CUI [2,3])
C0027769 (UMLS CUI [3])
C4054984 (UMLS CUI [4])
C0003467 (UMLS CUI [5])
C0700361 (UMLS CUI [6])
C0087111 (UMLS CUI [7,1])
C0558295 (UMLS CUI [7,2])
Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?
Code List
Question 3. Overall, with respect to your feelings associated with treatment (e.g., nervousness, fear, anxiety or other emotional distress) which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?
integer
C1522634 (UMLS CUI [1])
C4049986 (UMLS CUI [2])
C0871707 (UMLS CUI [3])
C0087111 (UMLS CUI [4,1])
C0558295 (UMLS CUI [4,2])
Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?
Code List
Question 4. Overall, with respect to the impact on your day-to-day activities before, during and after treatment, which treatment do you prefer?
CL Item
I prefer intravitreal injections (1)
CL Item
I prefer eye drops (2)
CL Item
I have no preference (3)
Item
Question 5a. If you could only have one treatment, which would you choose?
integer
C1522634 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C1707391 (UMLS CUI [2,2])
Question 5a. If you could only have one treatment, which would you choose?
Code List
Question 5a. If you could only have one treatment, which would you choose?
CL Item
Intravitreal injections (4)
CL Item
Eye drops (5)
Question 5b. What is the single most important reason for your choice?
Item
Question 5b. What is the single most important reason for your choice?
text
C1522634 (UMLS CUI [1])
C0392360 (UMLS CUI [2,1])
C1707391 (UMLS CUI [2,2])
Item Group
Eye Drop Administration
C0015399 (UMLS CUI-1)
C1533734 (UMLS CUI-2)
Item
Who has been primarily responsible for administering the medication (eye drops) over the study?
text
C0015399 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C0678341 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,4])
C0347984 (UMLS CUI [1,5])
Who has been primarily responsible for administering the medication (eye drops) over the study?
Code List
Who has been primarily responsible for administering the medication (eye drops) over the study?
CL Item
Caregiver (or equivalent) (1)
CL Item
Subject self-administers (2)
CL Item
Both subject and caregiver (3)
CL Item
Other, specify (OT)
If other person is responsible for administering the medication, specify
Item
If other person is responsible for administering the medication, specify
text
C0015399 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C0678341 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
C2348235 (UMLS CUI [1,5])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial